Systematic review / meta-analysis / 2022
NAD+ precursor supplementation improved lipid profiles but raised blood glucose levels in humans.
A meta-analysis of 40 articles (14,750 cases) evaluated the effects of NAD+ precursors (NR, NMN, NA, and NAM) on lipid and glucose metabolism. NAD+ precursor supplementation significantly reduced TG (SMD = -0.35, P < 0.0001), TC (SMD = -0.33, P = 0.0005), and LDL (SMD = -0.38, P < 0.00001), while increasing HDL (SMD = 0.66, P < 0.00001) and plasma glucose (SMD = 0.27, P = 0.0004). Subgroup analyses indicated nicotinic acid (NA) had the most significant effects on these markers, with significant benefits seen in patients with cardiovascular disease and dyslipidemia but little effect in healthy people. The authors note the conclusions are limited by the number and quality of included studies.
- Study type
- Meta-analysis of clinical studies
- Who was studied
- 14,750 participants across 40 clinical articles (7,406 intervention, 7,344 control)
- What was measured
- Levels of triglyceride (TG), total cholesterol (TC), LDL, HDL, and fasting blood glucose
THE PAPER
Effects of NAD+ precursor supplementation on glucose and lipid metabolism in humans: a meta-analysis.
Zhong O, Wang J, Tan Y, Lei X, Tang Z. Nutr Metab (Lond), 2022.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.